---

Overview

This sixth annual meeting represents the premier management and investment conference for the new and emerging bioelectronic medicine industry. Attendees will have an exclusive opportunity to interact with some of the key leaders driving this field forward. The schedule of presentations and panel discussions features a host of experts with a wealth of information on the neuroscience industry and the investment community.
Sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties. Attendees will hear from some of the leading researchers and entrepreneurs developing clinically and commercially promising products such as implanted vagus nerve stimulation systems to treat hypertension, and surface stimulation devices to treat a range of disorders.

Program

8:30-8:45: Welcome and Introductions

8:45-9:00: Overview of the Bioelectronic Medicine Industry

James Cavuoto, Editor, Neurotech Reports
BioElectRx Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including key players, technological roots, and market projections.

9:00-9:30: Keynote Address

Helen Mayberg, M.D., Director, Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai
One of the pioneers in the field of neuromodulation for psychiatric disorders discusses the interplay between pharmacological and device interventions in treating disease.

9:30-10:15: Investment in Bioelectronic Medicine

JoJo Platt, Senior Contributing Editor, Neurotech Reports - Moderator
Scott Levitt, Vice President, Pharmakon Advisors, LP
Josh Schulman, Ph.D., Chief Science Officer, Joy Ventures
In this session, investment professionals active in the life sciences industry will offer their views on the investment climate for bioelectronic medicine.

10:15-10:45: Refreshment Break

10:45-11:30: Entrepreneur Panel I

James Cavuoto, Editor, Neurotech Reports - Moderator
Brad Schmidt, Ph.D., CEO, Panaxium
Sandro Ferrari, Ph.D., Director of Operations, WISE srl
Presentations from executives of emerging bioelectronic medicine firms.

11:30-12:00: Exploiting the Enteric Nervous System

James Cavuoto, Editor, Neurotech Reports - Moderator
Victor Pikov, Ph.D., CEO, Medipace Inc.
Jennifer French, Executive Director, Neurotech Network
The brain-gut connection not only opens the door to new bioelectronic medicine therapies for gastrointestinal disorders, it also offers a potential back door to the CNS. In this session, we'll explore potential new therapies and opportunities to collaborate with biopharma firms.

12:00-1:00: Luncheon

1:00-1:30: Luncheon Speaker

Will Pitkin, Senior Director of Business Development and Neuromodulation Strategy, Cirtec Medical

1:30-2:15: Biomarkers Close the Loop in Bioelectronic Medicine

Victor Pikov, Ph.D., Contributing Editor, Neurotech Reports - Moderator
Marom Bikson, Ph.D., Professor of Biomedical Engineering, City College of New York
Immanuel Lerman, M.D., Founder, InflammaSense
The ability to track neural activity offers bioelectronic medicine vendors several advantages. In this session, we'll look at examples of closed-loop neuromodulation and discuss new areas that stand to beneift.

2:15-3:00: Entrepreneur Panel II

James Cavuoto, Editor, Neurotech Reports - Moderator
Marc Powell, Ph.D., CEO, Reach Neuro Inc.
Chris Czura, Ph.D., Senior Director of Scientific Affairs, Five Liters
Karen Crow, CEO and Co-Founder, NeuroGeneces
Presentations from executives of emerging bioelectronic medicine firms.

3:00-3:30: Refreshment Break

3:30-4:15: Entrepreneur Panel III

James Cavuoto, Editor, Neurotech Reports - Moderator
Christine Aytug, Director of Business Development, Evren Technologies
Jacob Robinson, Ph.D., Co-Founder and CEO, Motif Neurotech
Presentations from executives of emerging bioelectronic medicine firms.

4:15-5:00: Who Foots the Bill? New Economic Models and Reimbursement Options

Jeremy Koff, Senior Consulting Editor, Neurotech Reports - Moderator
Renee Ryan, CEO, Cala Health
Mark Domyahn, Partner, J.D. Lymon Group
Bioelectronic medicine therapies occupy some new terrain when it comes payment models and reimbursement strategies. In this session, we'll explore recent trends in device coverage and look at best practices for obtaining reimbursement.

5:00-6:30: Cocktail Reception

Register